Genetically proxied inhibition of tumor necrosis factor and the risk of colorectal cancer: A drug-target mendelian randomization study. (2022)

First Author: Chen M

Attributed to: UK Biobank (core renewal) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2022.1079953

PubMed Identifier: 36618924

Publication URI: http://europepmc.org/abstract/MED/36618924

Type: Journal Article/Review

Volume: 13

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812